Larvol Delta - IRX2-Cyclophosphamide-and-Nivolumab-in-Treating-Participants-With-Recurrent-or-Metastatic-and-Refractory-Liver-Cancer

Opdivo (nivolumab) - Ono Pharma, BMS

citoplurikin (IRX-2) - IRX Therapeutics

Revimmune (cyclophosphamide high dose) - Accentia

cyclophosphamide intravenous - generics

http://clinicaltrials.gov/ct2/show/NCT03655002

Jan 30, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next